Eco R1 Capital, LLC Kezar Life Sciences, Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$3.0 - $7.58 $1.75 Million - $4.42 Million	-583,293 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$7.09 - $21.9 $1.94 Million - $5.98 Million	-273,178 Reduced 31.9%	583,293 $4.5 Million
Q1 2019 May 15, 2019	SELL	$16.83 - $23.75 $3.43 Million - $4.83 Million	-203,547 Reduced 19.2%	856,471 $15.2 Million
Q4 2018 Feb 14, 2019	SELL	$20.21 - $32.9 $4.61 Million - $7.51 Million	-228,180 Reduced 17.71%	1,060,018 $25 Million
Q3 2018 Nov 14, 2018	BUY	$15.5 - $21.41 $248,000 - $342,560	16,000 Added 1.26%	1,288,198 $27.6 Million
Q2 2018 Aug 14, 2018	BUY	$17.15 - $17.79 $21.8 Million - $22.6 Million	1,272,198 New	1,272,198 $22 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.